
|Articles|June 1, 2003
Unoprostone increases outflow facility to reduce IOP
Author(s)Chet Scerra
Fort Lauderdale, FL-An increase in outflow facility appears to be the mechanism by which unoprostone isopropyl ophthalmic solution (Rescula 0.15%, Novartis) reduces IOP, said Carol B. Toris, PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
2
Redefining glaucoma care: Where innovation meets clinical insight
3
Beyond the surface: Tackling complex dry eye cases
4
Seborrheic dermatitis linked to multiple epithelial barrier diseases
5



















































.png)


